Rapid Micro Biosystems, Inc. (NASDAQ:RPID) CEO Sells $39,540.42 in Stock

Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Get Free Report) CEO Robert G. Jr. Spignesi sold 11,874 shares of the stock in a transaction dated Friday, July 11th. The shares were sold at an average price of $3.33, for a total transaction of $39,540.42. Following the transaction, the chief executive officer directly owned 957,286 shares of the company's stock, valued at $3,187,762.38. This trade represents a 1.23% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Rapid Micro Biosystems Stock Down 0.3%

Rapid Micro Biosystems stock traded down $0.01 during midday trading on Friday, reaching $3.44. The stock had a trading volume of 7,139 shares, compared to its average volume of 196,826. Rapid Micro Biosystems, Inc. has a 52-week low of $0.64 and a 52-week high of $4.04. The firm has a market cap of $150.78 million, a price-to-earnings ratio of -3.34 and a beta of 1.32. The company has a fifty day moving average of $3.38 and a 200 day moving average of $2.64.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last issued its earnings results on Friday, May 9th. The company reported ($0.26) EPS for the quarter, topping analysts' consensus estimates of ($0.27) by $0.01. Rapid Micro Biosystems had a negative net margin of 151.22% and a negative return on equity of 56.07%. The business had revenue of $7.21 million for the quarter, compared to analyst estimates of $6.63 million. Equities research analysts predict that Rapid Micro Biosystems, Inc. will post -1.1 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. American Century Companies Inc. acquired a new position in Rapid Micro Biosystems in the 1st quarter valued at about $31,000. Legato Capital Management LLC acquired a new position in Rapid Micro Biosystems in the 1st quarter valued at about $41,000. Millennium Management LLC raised its stake in shares of Rapid Micro Biosystems by 17.6% in the 4th quarter. Millennium Management LLC now owns 61,375 shares of the company's stock valued at $55,000 after acquiring an additional 9,191 shares during the period. Essex Investment Management Co. LLC purchased a new stake in shares of Rapid Micro Biosystems in the 1st quarter valued at approximately $166,000. Finally, Citadel Advisors LLC purchased a new stake in shares of Rapid Micro Biosystems in the 4th quarter valued at approximately $65,000. Hedge funds and other institutional investors own 52.60% of the company's stock.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.